Cite
Oral phosphodiesterase-5 inhibitors: effect of heme oxygenase inhibition on cGMP signalling in rat cavernous tissue
MLA
Hazem Atta, et al. “Oral Phosphodiesterase-5 Inhibitors: Effect of Heme Oxygenase Inhibition on CGMP Signalling in Rat Cavernous Tissue.” Andrologia, vol. 39, no. 2, Apr. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....55521261bd0f4c8390b2ad78e0676645&authtype=sso&custid=ns315887.
APA
Hazem Atta, Amal El-Shehaby, Taymour Mostafa, Samar Marzouk, Dina Sabry, Eman Obaia, L. Rashed, M. T. Abdel Aziz, Amira Hassouna, & Ahmed T. Abdel Aziz. (2007). Oral phosphodiesterase-5 inhibitors: effect of heme oxygenase inhibition on cGMP signalling in rat cavernous tissue. Andrologia, 39(2).
Chicago
Hazem Atta, Amal El-Shehaby, Taymour Mostafa, Samar Marzouk, Dina Sabry, Eman Obaia, L. Rashed, M. T. Abdel Aziz, Amira Hassouna, and Ahmed T. Abdel Aziz. 2007. “Oral Phosphodiesterase-5 Inhibitors: Effect of Heme Oxygenase Inhibition on CGMP Signalling in Rat Cavernous Tissue.” Andrologia 39 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....55521261bd0f4c8390b2ad78e0676645&authtype=sso&custid=ns315887.